EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Migraine and headache in children and adolescents: A 2026 evidence-based factsheet

Derya Uludüz iD, Ishaq Abu-Arafeh iD, Serena Laura Orr, Nazia Karsan iD, Vanda Faria iD, Nana Nino Tatishvili, Marco Lisicki iD, Toshiyuki Hikita iD, Hamit Genç iD, Aynur Özge iD

Cephalalgia · 2026-08 · 46 (8)

DOI: 10.1177/03331024261463173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cephalalgia, online erschienen am 06.08.2026. Verfasst von Derya Uludüz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Istanbul Atlas University, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Headache, Migraine Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Headache disorders, particularly migraine, are among the leading causes of disability worldwide, with onset frequently occurring during childhood and adolescence. Despite their high prevalence and substantial functional impact, paediatric headache disorders remain under-recognised within health systems and under-represented in global policy frameworks.

Methods

This factsheet was developed to provide a comprehensive, developmentally informed overview of the global burden of headache disorders in children and adolescents. It synthesises evidence from population-based studies, systematic reviews, clinical cohorts, and Global Burden of Disease (GBD) 2023 estimates. Key domains include epidemiology, disability burden, functional and psychosocial impacts, risk factors and triggers, diagnostic and treatment gaps, and current management strategies, with particular attention to disparities across sociodemographic groups.

Results

According to GBD 2023 point-prevalence estimates, headache disorders increase markedly across development, from 10.71% among children aged 5–9 years to 42.64% among adolescents aged 15–19 years. Corresponding migraine prevalence estimates increase from 2.79% to 18.08%. GBD 2023 data also indicate that migraine is among the leading causes of years lived with disability from early life onwards.Migraine in children and adolescents is associated with substantial impairment in school attendance, academic performance, social participation, and quality of life. It is also frequently accompanied by psychiatric and somatic comorbidities. Access to timely diagnosis and evidence-based treatment remains highly inequitable, particularly in low- and middle-income countries. Emerging evidence suggests that adolescence may represent a critical window for intervention, with the potential to reduce progression to chronic migraine and long-term disability.

Conclusions

Migraine and other headache disorders in children and adolescents constitute a major global public health challenge. This factsheet provides a comprehensive, evidence-based summary of their burden and highlights urgent priorities for policy integration, advocacy, and research. Early, equitable, and developmentally tailored care is essential to reduce lifelong disability and improve global brain health outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HeadacheMigraine DisordersAdolescentChildChild, PreschoolHumansGlobal Burden of DiseaseGlobal HealthPrevalenceRisk Factors

Stichwörter der Autor:innen

children and adolescentsdisabilityglobal burden of diseasemigrainepaediatric headachepublic health

Autor:innen und Institutionen

  • Department of Neurology, Istanbul Atlas University, Istanbul, Türkiye.
  • Paediatric Neurosciences Unit, Royal Hospital for Children, Glasgow, UK.
  • Departments of Pediatrics, Community Health Sciences, & Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.
  • Headache Group, Institute of Psychiatry, Psychology and Neuroscience, King's College London and Children's Headache Clinic, Department of Neurology, Great Ormond Street Hospital for Children, London, UK.
  • Department of Psychology, Uppsala University, Uppsala, Sweden.
  • Comprehensive Pain Center, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.

ORCID-Profile: Derya Uludüz, Ishaq Abu-Arafeh, Nazia Karsan, Vanda Faria, Marco Lisicki, Toshiyuki Hikita, Hamit Genç, Aynur Özge

Zitieren

APA

Uludüz, D., Abu-Arafeh, I., Orr, S. L., Karsan, N., Faria, V., Tatishvili, N. N., Lisicki, M., Hikita, T., Genç, H., & Özge, A. (2026). Migraine and headache in children and adolescents: A 2026 evidence-based factsheet. Cephalalgia, 46(8). https://doi.org/10.1177/03331024261463173

Vancouver

Uludüz D, Abu-Arafeh I, Orr SL, Karsan N, Faria V, Tatishvili NN, et al. Migraine and headache in children and adolescents: A 2026 evidence-based factsheet. Cephalalgia. 2026;46(8). doi:10.1177/03331024261463173

BibTeX
@article{Uludz2026,
  author = {Uludüz, Derya and Abu-Arafeh, Ishaq and Orr, Serena Laura and Karsan, Nazia and Faria, Vanda and Tatishvili, Nana Nino and Lisicki, Marco and Hikita, Toshiyuki and Genç, Hamit and Özge, Aynur},
  title = {Migraine and headache in children and adolescents: A 2026 evidence-based factsheet},
  journal = {Cephalalgia},
  year = {2026},
  volume = {46},
  number = {8},
  doi = {10.1177/03331024261463173}
}
Kostenlos starten →